Answer
The safety and efficacy of clesrovimab in children aged 1 to 18 years have not yet been established, and no data are available.
Sources for this answer
- ENFLONSIA® 105 mg solution for injection in pre-filled syringeMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.2 Posology and method of administration · Version 2Document updated
Sources checked